Catalyst Orthoscience, a medical device company focused on the upper extremity orthopedics market, recently named David Sharp its vice president of global marketing, effective immediately.
The appointment comes three months after the Naples-based firm named medical device industry leader Carl O’Connell as president and CEO.
Sharp brings more than 27 years of marketing, strategy, business development, communications and branding experience to his new role in the medical device industry. According to a statement, companies he has worked for include Sofmore Denek, Smith & Nephew, Medtronic Spinal & Biologics, Baxter International and most recently, Microport Orthopedics, according to a statement.
“We are excited to have an executive with David’s experience join our team at Catalyst Orthoscience,” O’Connell said in the release. “As we continue to grow and establish our presence as an emerging global leader in shoulder pathology solutions, David’s leadership and experience will help make that vision a reality.”
Catalyst Orthoscience, with the goal of developing innovative medical solutions that make orthopedic surgery less invasive and more efficient for both surgeons and patients, has a growing portfolio of patents and pending patents on its specialized surgical offerings. Its products are available across the U.S. In 2021 it won FDA approval for its new reverse shoulder implant system and closed a $12.5 million funding round.
“I am excited to join the Catalyst team and contribute to the company’s goals, which focus on sustainable growth and clinical development for shoulder surgeons and their patients around the world,” Sharp said in the statement. provide genuine solutions to limitless needs.” “I will focus on developing a best-in-class marketing team and brand as we continue to build our core foundations in sales, marketing, R&D, and MedEd.”
